Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Select black men are potential candidates for prostate hemi-ablation based on radical prostatectomy histopathology for intermediate-risk prostate cancer-a multicenter SEARCH cohort study.
Deivasigamani S, Adams ES, Stock S, Kotamarti S, Séguier D, Taha T, Howard LE, Aminsharifi A, Jibara G, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Klaassen Z, Guerrios-Rivera L, Freedland SJ, Polascik TJ. Deivasigamani S, et al. Prostate Cancer Prostatic Dis. 2024 Aug 12. doi: 10.1038/s41391-024-00880-6. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 39134653
Image-guided multiparametric magnetic resonance imaging-transrectal ultrasound fusion biopsy augmented with a sextant versus an extended template random biopsy: Comparison of cancer detection rates, complication and functional outcomes.
Adams ES, Deivasigamani S, Kotamarti S, Wolf S, Mottaghi M, Aminsharifi A, Taha T, Seguier D, Michael Z, Ivey M, Gupta RT, Polascik TJ. Adams ES, et al. Among authors: deivasigamani s. Prostate. 2024 Sep;84(13):1224-1233. doi: 10.1002/pros.24760. Epub 2024 Jun 26. Prostate. 2024. PMID: 38926139
Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before radical prostatectomy in the multiethnic SEARCH cohort.
Mottaghi M, Gu L, Deivasigamani S, Adams ES, Parrish J, Amling CL, Aronson WJ, Kane CJ, Terris MK, Guerrios-Rivera L, Cooperberg MR, Klaassen Z, Freedland SJ, Polascik TJ. Mottaghi M, et al. Among authors: deivasigamani s. Prostate Cancer Prostatic Dis. 2024 Apr 11. doi: 10.1038/s41391-024-00830-2. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 38605270
Urinary fatty acid biomarkers for prostate cancer detection.
Noriega Landa E, Quaye GE, Su X, Badmos S, Holbrook KL, Polascik TJ, Adams ES, Deivasigamani S, Gao Q, Annabi MH, Habib A, Lee WY. Noriega Landa E, et al. Among authors: deivasigamani s. PLoS One. 2024 Feb 9;19(2):e0297615. doi: 10.1371/journal.pone.0297615. eCollection 2024. PLoS One. 2024. PMID: 38335180 Free PMC article.
Comparison of procedural anxiety and pain associated with conventional transrectal ultrasound prostate biopsy to magnetic resonance imaging-ultrasound fusion-guided biopsy: a prospective cohort trial.
Deivasigamani S, Adams ES, Kotamarti S, Mottaghi M, Taha T, Aminsharifi A, Michael Z, Seguier D, Polascik TJ. Deivasigamani S, et al. Prostate Cancer Prostatic Dis. 2024 Jun;27(2):294-299. doi: 10.1038/s41391-023-00760-5. Epub 2023 Nov 25. Prostate Cancer Prostatic Dis. 2024. PMID: 38001362
37 results